Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Adlai Nortye Ltd (ADR) before investing.
In this article, we go over a few key elements for understanding Adlai Nortye Ltd (ADR)’s stock price such as:
- Adlai Nortye Ltd (ADR)’s current stock price and volume
- Why Adlai Nortye Ltd (ADR)’s stock price changed recently
- Upgrades and downgrades for ANL from analysts
- ANL’s stock price momentum as measured by its relative strength
About Adlai Nortye Ltd (ADR)
(ANL)
Before we jump into Adlai Nortye Ltd (ADR)’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The Company’s pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as three preclinical candidates. AN2025 is a pan-phosphoinositide 3-kinase (PI3K) inhibitor that is designed to act against solid tumors. AN2025 is undergoing Phase III, open-label clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas (HNSCC) after anti-programmed death-1 (PD-1) or its ligand (PD-L1) treatment. AN0025 is a small molecule prostaglandin E receptor 4 (EP4) antagonist. AN4005 is an internally discovered oral small molecule PD-L1 inhibitor in development to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include: AN8025, AN1025, and AN9025.
Want to learn more about Adlai Nortye Ltd (ADR)’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Adlai Nortye Ltd (ADR).
Adlai Nortye Ltd (ADR)’s Stock Price as of Market Close
As of May 03, 2024, 2:58 PM, CST, Adlai Nortye Ltd (ADR)’s stock price was $13.78.
Adlai Nortye Ltd (ADR) is up 5.84% from its previous closing price of $13.02.
During the last market session, Adlai Nortye Ltd (ADR)’s stock traded between $11.81 and $14.12. Currently, there are 14.45 million shares of Adlai Nortye Ltd (ADR) stock available for purchase.
Unfortunately, Adlai Nortye Ltd (ADR)’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.
Adlai Nortye Ltd (ADR) Stock Price History
Adlai Nortye Ltd (ADR)’s
(ANL) price is currently down 0.14% so far this month.
During the month of May, Adlai Nortye Ltd (ADR)’s stock price has reached a high of $14.13 and a low of $11.81.
Over the last year, Adlai Nortye Ltd (ADR) has hit prices as high as $19.30 and as low as $7.11.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Adlai Nortye Ltd (ADR) Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 02, 2024, there were analysts who downgraded Adlai Nortye Ltd (ADR)’s stock and analysts who upgraded over the last month.
Additionally, you'll want to evaluate Adlai Nortye Ltd (ADR)’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Adlai Nortye Ltd (ADR)’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Adlai Nortye Ltd (ADR)
(ANL) by visiting AAII Stock Evaluator.
Relative Price Strength of Adlai Nortye Ltd (ADR)
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of May 02, 2024, Adlai Nortye Ltd (ADR) has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.
Want to learn more about how Adlai Nortye Ltd (ADR) is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Adlai Nortye Ltd (ADR) Stock Price: Bottom Line
As of May 3, 2024, Adlai Nortye Ltd (ADR)’s stock price is $13.78, which is up 5.84% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Adlai Nortye Ltd (ADR) stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
Yield Screen: 8.7% Compared to S&P 500
at only 6.9%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.